Scientific publication with Newspaper speed
HIGH IMPACT, OUTSTANDING EDITORIAL BOARD, OVERNIGHT PUBLICATION, OPEN ACCESS, PROMOTION, HIGH VISIBILITY
Oncotarget publishes high-impact papers of outstanding significance and novelty in all areas of biology and medicine including cancer research and oncology.
Oncotarget is launching speciality sections to extend the scope of the journal beyond cancer research: Gerontology, Pathology, Bioinformatics, Pharmacology, Stem Cell, miRNA, Immunonolgy, Neurobiology, Cellular and Molecular Biology. Publish your Research Paper on any of these topics (unrelated to Oncology) in a journal with impact factor 6.63.
If your paper was mistakenly rejected by other leading journals, you may submit it to Oncotarget (see our policy) together with peer-reviews obtained from the other journal and rebuttal letter.
Now hiring (full, part-time or contractors):
English editors, Scientific Translation Editors (from Chinese to English):
Email CV to firstname.lastname@example.org
Marketing, finance, IT specialists, managers, managing editors:
Email CV to email@example.com
|07/30/2014||New IF: IF2013 = 6.63|
|07/23/2014||Elsevier has released the latest Journal Metrics based on Scopus data: SCImago Journal Rank (SJR). For Oncotarget, SJR 2013 increased by 24% compared with the last year SJR 2012.|
|12/30/2013||Our new submission system is online oncotarget.msubmit.net. See link for earlier papers.|
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
Copyright @ 2008-2015 Impact Journals, LLC. All rights reserved.
Impact Journals is a trademark of Impact Journals,LLC